Filing Details
- Accession Number:
- 0001209191-21-013036
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-22 21:33:19
- Reporting Period:
- 2021-02-09
- Accepted Time:
- 2021-02-22 21:33:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1124105 | Catalyst Biosciences Inc. | CBIO | Pharmaceutical Preparations (2834) | 562020050 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1672333 | Howard Levy | 611 Gateway Boulevard, Suite 710 South San Francisco CA 94080 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-09 | 1,670 | $4.81 | 23,390 | No | 5 | P | Indirect | By Howard and Gillian Levy Revocable Trust dated November 21, 1994 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Indirect | By Howard and Gillian Levy Revocable Trust dated November 21, 1994 |
Footnotes
- Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on February 9, 2021.
Billionaire Hedge Funds
